Drug Utilization Evaluation of Antidepressant Prescribing Practice in a Psychiatric Outpatient Hospital: A Prospective Cross-Sectional Study

Vaishnavi Uppula

Department of Pharmacy Practice, Care College of Pharmacy, Hanamkonda, TS, India.

Tejasri Nitturi

Department of Pharmacy Practice, Care College of Pharmacy, Hanamkonda, TS, India.

Satyanarayana SV Padi *

Department of Pharmacy Practice, Care College of Pharmacy, Hanamkonda, TS, India.

Jagadeesh Babu Bandari

Jaya Krishna Psychiatric Care and Counselling Centre, Hanamkonda, TS, India.

Manjula Puluru

Department of Pharmacy Practice, Care College of Pharmacy, Hanamkonda, TS, India.

*Author to whom correspondence should be addressed.


Abstract

Background: One of the main causes of morbidity is psychiatric disorders, which are becoming a burden to public health. The therapeutic choices are influenced by several factors, including treatment paradigms, safety, and costs that determine outcomes.

Aim: We carried out the drug utilization evaluation (DUE) of antidepressants in patients visiting the psychiatry outpatient department. 

Study Design: An observational, prospective, and cross-sectional study.

Place and Duration of Study: Department of Psychiatry, Jaya Krishna Hospital, Hanamkonda, TS, between September 2021 to April 2022.

Methodology: We included patients who visited the psychiatric outpatient hospital, were clinically diagnosed, and received any antidepressants for the long term. The relevant data collected from the information resources was systematically analyzed for DUE.

Results: Among 417 patients, the majority were in the age group of 31-40 (33.3%) years, and the most affected were female (57.3%), married (73.4%), and housewives (29.5%). Depression (37.6%) was the most commonly diagnosed psychiatric disorder. Of these prescriptions, 5.3% were monotherapy, the remaining was polytherapy (94.7%), and the majority of them had three drugs (36.2%). The average number of drugs per encounter was 3.4, drugs prescribed by generic names were 41.4%, injectable drugs prescribed were 2.6%, and drugs listed in the National List of Essential Medicines were 61.3%. Of all, 88.7% of prescriptions had at least one antidepressant, predominantly SSRIs, and fluoxetine (23.0%) was the most commonly prescribed. Benzodiazepines (59.7%) were the most frequently prescribed concomitant drug class and clonazepam (50.6%) was the most widely prescribed. Suicidal thoughts (5.8%) were the most commonly observed ADR.

Conclusion: The study observed a pattern of polytherapy, mainly antidepressants from the SSRIs, notably fluoxetine mostly prescribed, and suicidal thoughts were the frequent ADR. Drug use surveillance studies, rationalizing therapeutic choices, and proper patient counseling would improve therapeutic outcomes by minimizing side effects and ADRs.

Keywords: Antidepressants, adverse drug reaction, depression; drug utilization, fluoxetine, psychiatry


How to Cite

Uppula, V., Nitturi, T., Padi, S. S., Bandari, J. B. and Puluru, M. (2024) “Drug Utilization Evaluation of Antidepressant Prescribing Practice in a Psychiatric Outpatient Hospital: A Prospective Cross-Sectional Study”, Journal of Pharmaceutical Research International, 36(7), pp. 1–12. doi: 10.9734/jpri/2024/v36i77533.

Downloads

Download data is not yet available.

References

Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137-150.

Meghrajani VR, Marathe M, Sharma R, Potdukhe A, Wanjari MB, Taksande AB. A comprehensive analysis of mental health problems in india and the role of mental asylums. Cureus. 2023;15(7):e42559.

Bashar MA, Mehra A, Aggarwal AK. Integrating mental health into primary care for addressing depression in a rural population: An experience from North India. Indian J Psychiatry. 2019;61(3):319-321.

Mehdi S, Manohar K, Shariff A, Wani SUD, Almuqbil M, Alshehri S, Shakeel F, Imam MT, Krishna KL. Analysis of Antidepressants Utilization for Patients Visiting Psychiatric Out-Patient Clinic in a Tertiary Care Hospital. Healthcare (Basel). 2022;10(10):2081.

Lunghi C, Dugas M, Leclerc J, Poluzzi E, Martineau C, Carnovale V, Stéfan T, Blouin P, Lepine J, Jalbert L, Suarez NR. Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review. BMJ open. 2022 ;12(5):e062197.

Ramamurthy P, Alexander A, Solomon S, Thilakan P, Rudravaram VV. Prescription pattern, follow-up pattern, and medication adherence in psychiatric outpatients. Annals of Indian Psychiatry. 2021;5(1):67-73.

Hadia R, Sanghani B, Sajan S, Mathew T, Rathod T, Joshi D, Maheshwari R, Baile S, Kardani S, Rajput HS. A drug use evaluation study on antidepressants in psychiatric patients at a tertiary care teaching hospital. J Pharmaceutic Res Int. 2021;1:66-75.

Tejus A, Saxena SK, Dwivedi AK, Salmani MF, Pradhan S. Analysis of the prescription pattern of psychotropics in an outpatient department of a general hospital psychiatry unit. Med J Armed Forces India. 2022;78(1):74-79.

Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA. National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey-based analysis. Frontiers in psychiatry. 2020; 11:35.

Lampela P, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Switches and early discontinuations of antidepressant medication in young adults with depression. J Affect Disord. 2021; 295:1474-1481.

Chen Q, Huang S, Xu H, Peng J, Wang P, Li S, Zhao J, Shi X, Zhang W, Shi L, Peng Y, Tang X. The burden of mental disorders in Asian countries, 1990-2019: an analysis for the global burden of disease study 2019. Transl Psychiatry. 2024;14(1):167.

Papola D, Ostuzzi G, Todesco B, Gastaldon C, Hanna F, Chatterjee S, van Ommeren M, Barbui C. Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders. Lancet Psychiatry. 2023; 10(10):809-816.

Tejashwini K, Bhushan A, Suma S, Katte R. Drug utilization pattern and adverse drug reactions in patients on antidepressants. Nat J Physiol Pharm Pharmacol. 2019;9(1):4-11.

Mohan P, Singh H, Sinha S, Prabhakaran K. Pharmacological Profile of Prescriptions Containing Antidepressants. J Marine Med Soc. 2021; 23(1):29-32.

Abegaz TM, Sori LM, Toleha HN. Self-Reported Adverse Drug Reactions, Medication Adherence, and Clinical Outcomes among Major Depressive Disorder Patients in Ethiopia: A Prospective Hospital Based Study. Psychiatry J. 2017;2017:5812817.

Afanasjeva J, Burk M, Cunningham FF, Fanikos J, Gabay M, Hayes GJ, Masters PL, Rodriguez R, Sinnett MJ. ASHP Guidelines on Medication-Use Evaluation. Am J Health Syst Pharm. 2021;78(2):168-175.

Razdan D, Yadav S, Gudibanda KR, Dudhraj V, Anand S, Kaur S, Bahl A. Assessing prescribing practices in Indian health facilities: a comprehensive review. Int J Community Med Public Health. 2023;10:5095-101.

Dutta S, Kaul V, Beg MA, Singh NK, Dutta S, Bawa S. A comparative drug utilization study of depression patients between tertiary care teaching hospital and private practitioners of Dehradun City, Uttarakhand. J Drug Deliv Ther 2015;5:45-9.

Kundakovic M, Rocks D. Sex hormone fluctuation and increased female risk for depression and anxiety disorders: From clinical evidence to molecular mechanisms. Front Neuroendocrinol. 2022;66:101010.

Sanchez-Ruiz JA, Leibman NI, Larson NB, Jenkins GD, Ahmed AT, Nunez NA, Biernacka JM, Winham SJ, Weinshilboum RM, Wang L, Frye MA, Ozerdem A. Age-dependent sex differences in the prevalence of selective serotonin reuptake inhibitor treatment: a retrospective cohort analysis. J Womens Health (Larchmt). 2023;32(11):1229-1240.

Bastaki K, El Anbari M, Ghuloum S, Jithesh PV. Prescription pattern of antidepressants and the potential for personalized medicine in the Qatari population. J Personalized Med. 2021;11(5):406.

Bansal N, Hudda M, Payne RA, Smith DJ, Kessler D, Wiles N. Antidepressant use and risk of adverse outcomes: population-based cohort study. Br J Psych Open. 2022;8(5):e164.

Chee KY, Tripathi A, Avasthi A, Chong MY, Xiang YT, Sim K, Kanba S, He YL, Lee MS, Chiu HF, Yang SY. Prescribing pattern of antidepressants in children and adolescents: findings from the research on Asia psychotropic prescription pattern. East Asian Archives of Psychiatry. 2016;26(1):10-7.

Del Pino-Sedeño T, Infante-Ventura D, Hernández-González D, González-Hernández Y, González de León B, Rivero-Santana A, Hurtado I, Acosta Artiles FJ. Sociodemographic and clinical predictors of adherence to antidepressants in depressive disorders: a systematic review with a meta-analysis. Front Pharmacol. 2024;15:1327155.

Lo HK, Tong CC, Chan JK, Kam CT, Wong CS, Cheng CP, Ho C, Leung BM, Wong WS, Yu ZH, Chang WC. Temporal trends of antidepressant utilization patterns in children and adolescents in Hong Kong: A 14-year population-based study with join point regression analysis. J Affective Disorders. 2024;344:61-8.

Jain C, Srivastava B, Agarwal RK. Analysis of antidepressant drugs utilization pattern in a tertiary care teaching hospital in Kumaon region. Int J Acad Med Pharm. 2023;5(4):1505-9.

Kulkarni VA, Baig MS, Deshpande P. Study of the prescription pattern of anti-depressants in a tertiary care hospital: a prospective observational study. Int J Res Med Sci. 2023;11(4):1251.

Anusha VL, Begum SS, Rajesh A. Drug utilization study in the department of psychiatry. Int J Sci Res Archive. 2023;8(1):740-53.

Huang CY, Yang SY, Mojtabai R, Lin SK, He YL, Chong MY, Ungvari G, Tan CH, Xiang YT, Sartorius N, Shinfuku N. Trends of polypharmacy and prescription patterns of antidepressants in Asia. J Clin Psychopharmacol. 2018;38(6):598-603.

Lunghi C, Antonazzo IC, Burato S, Raschi E, Zoffoli V, Forcesi E, Sangiorgi E, Menchetti M, Roberge P, Poluzzi E. Prevalence and determinants of long-term utilization of antidepressant drugs: a retrospective cohort study. Neuropsychiatric Dis Treatment. 2020: 1157-70.

Cosgrove L, Patterson EH, Bursztajn HJ. Industry influence on mental health research: depression as a case example. Front Med (Lausanne). 2024;10:1320304.

Kesselheim AS, Gagne JJ, Franklin JM, Eddings W, Fulchino LA, Avorn J, Campbell EG. Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey. J Gen Intern Med. 2016;31(6):609-14.

Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLoS Med. 2019;16(3):e1002763.

Hsu CW, Lee SY, Yang YH, Wang LJ. Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan. Int J Neuropsychopharmacol. 2020;23(10):653-661.

Todesco B, Ostuzzi G, Barbui C. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level. Epidemiol Psychiatr Sci. 2022;31:e22.

Paul SM, Potter WZ. Finding new and better treatments for psychiatric disorders. Neuropsychopharmacol. 2024;49:3–9.

Todesco B, Ostuzzi G, Gastaldon C, Papola D, Barbui C. Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations. Arch Public Health. 2023;81(1):8.

Yerkade V, Siddiqui RA. A drug utilization study of antidepressant drugs in a tertiary care hospital. Int J Basic Clin Pharmacol. 2017; 6(6):1405–1409.

Alemi F, Min H, Yousefi M, Becker LK, Hane CA, Nori VS, Wojtusiak J. Effectiveness of common antidepressants: a post market release study. eClinicalMedicine. 2021;41:101171.

Pillai A, Keyes KM, Susser E. Antidepressant prescriptions and adherence in primary care in India: Insights from a cluster randomized control trial. PLoS One. 2021;16(3):e0248641.

Horowitz MA, Framer A, Hengartner MP, Sørensen A, Taylor D. Estimating Risk of Antidepressant Withdrawal from a Review of Published Data. CNS Drugs. 2023;37(2):143-157.

González de León B, Abt-Sacks A, Acosta Artiles FJ, Del Pino-Sedeño T, Ramos-García V, Rodríguez Álvarez C, Bejarano-Quisoboni D, Trujillo-Martín MM. Barriers and Facilitating Factors of Adherence to Antidepressant Treatments: An Exploratory Qualitative Study with Patients and Psychiatrists. Int J Environ Res Public Health. 2022;19(24):16788.

Lagerberg T, Matthews AA, Zhu N, Fazel S, Carrero JJ, Chang Z. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation. Neuropsychopharmacol. 2023;48(12):1760-1768.

Dubrall D, Fekete S, Leitzen S, Paschke LM, Romanos M, Schmid M, Gerlach M, Sachs B. Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases. BMC Pharmacol Toxicol. 2023;24(1): 22.

Spielmans GI, Spence-Sing T, Parry P. Duty to Warn: Antidepressant black box suicidality warning is empirically justified. Front Psychiatry. 2020;11:18.

Li K, Zhou G, Xiao Y, Gu J, Chen Q, Xie S, Wu J. Risk of suicidal behaviors and antidepressant exposure among children and adolescents: a meta-analysis of observational studies. Front Psychiatry. 2022;13:880496.

Niarchou E, Roberts LH, Naughton BD. What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review. J Psychopharmacol. 2024;38(2):127-36.